Do cancer and treatment type affect distress?

Psycho-Oncology

Volumn 22, Issue 8, 2013, Pages 1766-1773

  Admiraal, J M ^a   Reyners, A K L ^a   Hoekstra Weebers, J E H M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Integraal Kankercentrum Noord Nederland   (Netherlands)

Author keywords

cancer; cancer type; cutoff; distress thermometer; oncology; screening

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISTRESS SYNDROME; FEMALE; FOLLOW UP; GENDER; HEAD AND NECK CANCER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PALLIATIVE THERAPY; PHYSICIAN; PREDICTIVE VALUE; PROSTATE CANCER; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SARCOMA; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY;

CANCER; CANCER TYPE; CUTOFF; DISTRESS THERMOMETER; ONCOLOGY; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANXIETY; ANXIETY DISORDERS; BREAST NEOPLASMS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; NETHERLANDS; PROSTATIC NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; ROC CURVE; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84880703140     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3211     Document Type: Article

References (64)

1. Hoekstra-Weebers JE,. Psychosociale signalering in de regio van het Integraal Kankercentrum Noord Oost (IKNO). Ned Tijdschr Oncol 2010; 7: 238-246.
2. Knobf MT,. Psychosocial responses in breast cancer survivors. Semin Oncol Nurs 2007; 27: 71-83. DOI: 10.1016/j.soncn.2011.05.001.
3. Mitchell AJ,. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007; 25: 4670-4681. DOI: 10.1200/JCO.2006.10.0438.
4. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S,. The prevalence of psychological distress by cancer site. Psycho-Oncology 2001; 10: 19-28. DOI: 10.1002/1099-1611(200101/02).
5. Holland JC, Bultz BD,. The NCCN guideline for distress management: a case for making distress the sixth vital sign. Natl Compr Canc Netw 2007; 5: 3-7.
6. Holland JC, Alici YA,. Management of distress in cancer patients. J Support Oncol 2010; 8: 4-12.
7. Hoekstra-Weebers J, Leenhouts G,. Signaleren van psychosociale problematiek. In Psychologische Patiëntenzorg in de Oncologie: Handboek voor de Professional, de Haes H, Gualthérie van Weezel L, Sanderman R, (eds). Koninklijke van Gorcum: Assen, 2009; 167-182.
8. Carlson LE, Bultz BD,. Cancer distress screening: needs, models, and methods. J Psychosom Res 2003; 55: 403-409. DOI: 10.1016/S0022-3999(03)00514-2.
9. Bultz BD, Johansen C,. Screening for distress, the 6th vital sign: where are we, and where are we going? Psycho-Oncology 2011; 20: 569-571. DOI: 10.1002/pon.1986.
10. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC,. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998; 82: 1904-1908.
11. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: distress management V.1. 2010. Retrieved on December 20, 2011 from www.nccn.org.
12. Mitchell AJ,. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. Natl Compr Canc Netw 2010; 8: 487-494.
13. Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE,. Screening and referral for psychosocial distress in oncologic practice. Cancer 2008; 113: 870-878. DOI: 10.1002/cncr.23622.
14. Comprehensive Cancer Center Netherlands. Dutch guideline: screening for psychosocial distress, version: 1.0. 2010. Retrieved on December 20, 2011 from http://www.oncoline.nl/index.php?language=en.
15. Merport A, Bober SL, Grose A, Recklitis CJ,. Can the distress thermometer (DT) identify significant psychological distress in long-term cancer survivors? a comparison with the brief symptom inventory-18 (BSI-18). Support Care Cancer 2012; 20: 195-198. DOI: 10.1007/s00520-011-1269-7.
16. Dolbeault S, Bredart A, Mignot V, et al., Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer. Palliat Support Care 2008; 6: 107-117. DOI: 10.1017/S1478951508000187.
17. Gunnarsdottir S, Thorvaldsdottir GH, Fridriksdottir N, et al., The psychometric properties of the Icelandic version of the distress thermometer and problem list. Psycho-Oncology 2012; 21: 730-736. DOI: 10.1002/pon.1950.
18. Jacobsen PB, Donovan KA, Trask PC, et al., Screening for psychologic distress in ambulatory cancer patients. Cancer 2005; 103: 1494-1502. DOI: 10.1002/cncr.20940.
19. Hawkes AL, Hughes KL, Hutchison SD, Chambers SK,. Feasibility of brief psychological distress screening by a community-based telephone helpline for cancer patients and carers. BMC Cancer 2010; 10: 14. DOI: 10.1186/1471-2407-10- 14.
20. Gil F, Grassi L, Travado L, Tomamichel M, Gonzalez JR,. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer 2005; 13: 600-606. DOI: 10.1007/s00520-005-0780-0.
21. Shim EJ, Shin YW, Jeon HJ, Hahm BJ,. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list. Psycho-Oncology 2008; 17: 548-555. DOI: 10.1002/pon.1275.
22. Özalp E, Cankurtaran ES, Soygür H, Özdemir Geyik P, Jacobsen PB,. Screening for psychological distress in Turkish cancer patients. Psycho-Oncology 2007; 16: 304-311. DOI: 10.1002/pon.1059.
23. Ransom S, Jacobsen PB, Booth JM,. Validation of the distress thermometer with bone marrow transplant patients. Psycho-Oncology 2006; 15: 604-612. DOI: 10.1002/pon.993.
24. Patel D, Sharpe L, Thewes B, Bell ML, Clarke S,. Using the distress thermometer and hospital anxiety and depression scale to screen for psychosocial morbidity in patients diagnosed with colorectal cancer. J Affect Disord 2011; 131: 412-416. DOI: 10.1016/j.jad.2010.11.014.
25. Baken DM, Woolley C,. Validation of the distress thermometer, impact thermometer and combinations of these in screening for distress. Psycho-Oncology 2011; 20: 609-614. DOI: 10.1002/pon.1934.
26. Grassi L, Sabato S, Rossi E, Marmai L, Biancosino B,. Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the distress thermometer from the southern European psycho-oncology study (SEPOS). J Affect Disord 2009; 114: 193-199. DOI: 10.1016/j.jad.2008.07.016.
27. Hoffman BM, Zevon MA, D'Arrigo MC, Cecchini TB,. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psycho-Oncology 2004; 13: 792-799. DOI: 10.1002/pon.796.
28. Tang L, Zhang Y, Pang Y, Zhang H, Song L,. Validation and reliability of distress thermometer in Chinese cancer patients. Chin J Cancer Res 2011; 23: 54-58. DOI: 10.1007/s11670-011-0054-y.
29. Wang G, Hsu S, Feng A, et al., The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan. Psycho-Oncology 2011; 20: 639-646. DOI: 10.1002/pon.1952.
30. Decat CS, Laros JA, Araujo TC,. Termômetro de distress: validação de um instrumento breve para avaliação diagnóstica de pacientes oncológicos. PsicoUSF 2009; 14: 253-260.
31. Yong HW, Zubaidah J, Saidi M, Zailina H,. Validation of Malaysian translated distress thermometer with problem checklist among the breast cancer survivors in Malaysia. Asian J Psychiatry 2012; 5: 38-42. DOI: 10.1016/j.ajp.2011.12.007.
32. Akizuki N, Akechi T, Nakanishi T, et al., Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 2003; 97: 2605-2613. DOI: 10.1002/cncr.11358.
33. Bevans M, Wehrlen L, Prachenko O, Soeken K, Zabora J, Wallen GR,. Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. Psycho-Oncology 2011; 20: 615-622. DOI: 10.1002/pon.1906.
34. Craike MJ, Livingston PM, Warne C,. Sensitivity and specificity of the distress impact thermometer for the detection of psychological distress among CRC survivors. J Psychosoc Oncol 2011; 29: 231-241. DOI: 10.1080/07347332.2011. 563347.
35. Gessler S, Low J, Daniells E, et al., Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psycho-Oncology 2008; 17: 538-547. DOI: 10.1002/pon.1273.
36. Mehnert A, Müller D, Lehmann C, Koch U,. Die deutsch version des NCCN distress-thermometers. Empirische überprüfung eines eines screening-instruments zur erfassung psychosozialer belastung bei krebspatienten. Z Psychiatr Psychol Psychother 2006; 54: 213-223.
37. Goebel S, Mehdorn HM,. Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 2011; 104: 357-364. DOI: 10.1007/s11060-010-0501-5.
38. Bidstrup PE, Mertz BG, Dalton SO, et al., Accuracy of the Danish version of the 'distress thermometer'. Psycho-Oncology 2011; 21: 436-443. DOI: 10.1002/pon.1917.
39. Bulli F, Miccinesi G, Maruelli A, Katz M, Paci E,. The measure of psychological distress in cancer patients: the use of distress thermometer in the oncological rehabilitation center of Florence. Support Care Cancer 2009; 17: 771-779. DOI: 10.1007/s00520-008-0543-9.
40. Bannink M,. Het optimaliseren van psychosociale zorg in de oncologie. Ned Tijdschr Oncol 2010; 7: 236-237.
41. Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C,. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer 2011; 105: 1814-1817. DOI: 10.1038/bjc.2011.503.
42. Bjelland I, Dahl A, Haug TT, Neckelmann D,. The validity of the hospital anxiety and depression scale-an updated literature review. J Psychosom Res 2002; 52: 69-77.
43. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM,. A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363-370.
44. Zweig MH, Campbell G,. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
45. Hintze J,. PASS 11. NCSS, LLC. Kaysville, Utah. 2011. Retrieved on July 2, 2012 from www.ncss.com.
46. Cohen J,. Statistical power analysis for the behavioral sciences. Erlbaum: Hilldale, NJ, 1988.
47. Faul F, Erdfelder E, Lang A, Buchner A,. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91. DOI: 10.3758/BF03193146.
48. Carlson LE, Angen M, Cullum J, et al., High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004; 90: 2297-2304. DOI: 10.1038/sj.bjc.6601887.
49. van Scheppingen C, Schroevers MJ, Smink A, et al., Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psycho-Oncology 2011; 20: 655-663. DOI: 10.1002/pon.1939.
50. Johansson E, Steineck G, Holmberg L, et al., Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian prostate cancer group-4 randomised trial. Lancet Oncol 2011; 12: 891-899. DOI: 10.1016/S1470-2045(11)70162-0.
51. Aiken LS, West SG,. Multiple Regression: Testing and Interpreting Interactions. Sage: Newbury Park (Calif), 1991.
52. Holmbeck GN,. Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. J Pediatr Psychol 2002; 27: 87-96.
53. Braeken AP, Lechner L, Houben RM, Van Gils FC, Kempen GI,. Psychometric properties of the screening inventory of psychosocial problems (SIPP) in Dutch cancer patients treated with radiotherapy. Eur J Cancer Care 2011; 20: 305-314. DOI: 10.1111/j.1365-2354.2010.01182.x.
54. Potosky AL, Reeve BB, Clegg LX, et al., Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 2002; 94: 430-437.
55. Sanda MG, Dunn RL, Michalski J, et al., Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261.
56. Collin SM, Martin RM, Metcalfe C, et al., Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 2008; 9: 445-452. DOI: 10.1016/S1470-2045(08)70104-9.
57. Thomas BC, NandaMohan V, Nair MK, Pandey M,. Gender, age and surgery as a treatment modality leads to higher distress in patients with cancer. Support Care Cancer 2010; 19: 239-250. DOI: 10.1007/s00520-009-0810-4.
58. Snowden A, White CA, Christie Z, Murray E, McGowan C, Scott R,. The clinical utility of the distress thermometer: a review. Br J Nurs 2011; 20: 220-227.
59. Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ,. Psychosocial issues confronting young women with breast cancer. Breast Dis 2005-2006; 23: 103-113.
60. Henselmans I, Sanderman R, Baas PC, Smink A, Ranchor AV,. Personal control after a breast cancer diagnosis: stability and adaptive value. Psycho-Oncology 2009; 18: 104-108. DOI: 10.1002/pon.1333.
61. Henselmans I, Helgeson VS, Seltman H, de Vries J, Sanderman R, Ranchor AV,. Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol 2010; 29: 160-168. DOI: 10.1037/a0017806.
62. Pinquart M, Fröhlich C,. Psychosocial resources and subjective well-being of cancer patients. Psychol Health 2009; 24: 407-421. DOI: 10.1080/08870440701717009.
63. Bidstrup PE, Johansen C, Mitchell AJ,. Screening for cancer-related distress: summary of evidence from tools to programmes. Acta Oncol 2011; 50: 194-204. DOI: 10.3109/0284186X.2010.533192.
64. Vodermaier A, Linden W, Siu C,. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009; 101: 1464-1488. DOI: 10.1093/jnci/djp336.